BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2381284)

  • 21. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinopeptides and fibrin gel structure.
    Blombäck B; Bark N
    Biophys Chem; 2004 Dec; 112(2-3):147-51. PubMed ID: 15572242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis.
    Nossel HL
    N Engl J Med; 1976 Aug; 295(8):428-32. PubMed ID: 59314
    [No Abstract]   [Full Text] [Related]  

  • 24. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
    Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
    Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassays of human fibrinopeptides A and B.
    Budzyński AZ; Marder VJ
    Pol Arch Med Wewn; 1978 Jan; 59(1):43-8. PubMed ID: 349523
    [No Abstract]   [Full Text] [Related]  

  • 26. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
    Profumo A; Turci M; Damonte G; Ferri F; Magatti D; Cardinali B; Cuniberti C; Rocco M
    Biochemistry; 2003 Oct; 42(42):12335-48. PubMed ID: 14567695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic aspects of release of fibrinopeptides AP and AY by human alpha-thrombin.
    De Cristofaro R; Castagnola M
    Haemostasis; 1991; 21(2):85-90. PubMed ID: 1959802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography.
    Southan C; Thompson E; Lane DA
    Thromb Res; 1986 Jul; 43(2):195-204. PubMed ID: 3738859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital dysfibrinogenemia.
    Rupp C; Beck EA
    Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of some unusual effects of calcium binding to fibrinogen.
    Mihalyi E
    Biophys Chem; 2004 Dec; 112(2-3):131-40. PubMed ID: 15572240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinopeptides. IV. Synthesis of human fibrinopeptide A.
    Channabasavaiah K; Sivanandaiah KM
    Int J Pept Protein Res; 1976; 8(3):323-9. PubMed ID: 931670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.
    Thomas DW; Schauster JL; Hoffman MD; Wilner GD
    J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
    Ni F; Zhu Y; Scheraga HA
    J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The action of thrombin on modified fibrinogen.
    Osbahr AJ
    Thromb Haemost; 1983 Jun; 49(3):208-13. PubMed ID: 6410533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.
    Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA
    Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of extravascular clotting on fibrinopeptide A levels in blood.
    Wilner GD; Chatpar P; Te A; Horowitz J
    J Lab Clin Med; 1978 Feb; 91(2):205-13. PubMed ID: 621423
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular basis for measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Hemost Thromb; 1978; 4():211-48. PubMed ID: 152445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.